By
Drug Target Review2025-07-15T13:30:05
Researchers in Japan have developed long-lasting 3D liver organoids from stem cells by incorporating bile acids into the culture medium - offering a new model for studying chronic liver diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-17T12:40:00Z
2026-06-17T09:14:00Z
2024-02-02T15:48:26
Sponsored by Bio-Techne
2023-03-23T14:46:21
Sponsored by Bio-Techne
2026-05-22T07:38:00
Contributor Dr Helen Bright, By Drug Target Review
2026-06-01T07:00:00
Contributor Dr Timothy O’Connor, By Drug Target Review
Site powered by Webvision Cloud